AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
17min chapter
Rerun: Lars Fruergaard Jørgensen CEO of Novo Nordisk
In Good Company with Nicolai Tangen
Innovations and Challenges in Obesity Treatment
This chapter explores the advances in obesity treatment through a novel GLP-1 medication developed by a long-established diabetes-focused pharmaceutical company. It addresses the complexities of ensuring accessibility and affordability for patients in different economic regions, particularly in the U.S. versus Europe, and highlights the financial motivations driving innovation in healthcare. The conversation underscores the importance of maintaining medical oversight and addressing regulatory challenges to enhance patient access to innovative treatments.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode